| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Early Benefit Assessments in Oncology in Germany: How Can a Clinically Relevant Endpoint Not Be Relevant to Patients?
|
Ruof, Jörg
|
|
2015
|
15 |
3 |
p. 221-226
|
artikel
|
| 2 |
Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment
|
Ouwerkerk-Mahadevan, Sivi
|
|
2015
|
15 |
3 |
p. 261-270
|
artikel
|
| 3 |
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
|
Rodby, Roger A.
|
|
2015
|
15 |
3 |
p. 271-279
|
artikel
|
| 4 |
Imeglimin: A Potential New Multi-Target Drug for Type 2 Diabetes
|
Vuylsteke, Valerie
|
|
2015
|
15 |
3 |
p. 227-232
|
artikel
|
| 5 |
Molecular Insight in the Multifunctional Effects of Oridonin
|
Owona, Brice Ayissi
|
|
2015
|
15 |
3 |
p. 233-244
|
artikel
|
| 6 |
Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial
|
Ambery, Claire L.
|
|
2015
|
15 |
3 |
p. 281-291
|
artikel
|
| 7 |
Stability of Melphalan in 0.9 % Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection
|
Desmaris, Romain-Pacôme
|
|
2015
|
15 |
3 |
p. 253-259
|
artikel
|
| 8 |
Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes
|
Ito, Rika
|
|
2015
|
15 |
3 |
p. 245-251
|
artikel
|
Tijdschrift beschrijving